Prognostic molecular markers in hepatocellular carcinoma: A systematic review
- 30 April 2007
- journal article
- review article
- Published by Elsevier BV in European Journal of Cancer
- Vol. 43 (6), 979-992
- https://doi.org/10.1016/j.ejca.2007.01.004
Abstract
No abstract availableThis publication has 113 references indexed in Scilit:
- Genomic signatures to guide the use of chemotherapeuticsNature Medicine, 2006
- Clinicopathological features, post-surgical survival and prognostic indicators of elderly patients with hepatocellular carcinomaEuropean Journal of Surgical Oncology, 2006
- p53, Ki-67, and serum alpha feto-protein as predictors of hepatocellular carcinoma recurrence in liver transplant patientsLaboratory Investigation, 2005
- Prognostic significance of Bcl-xL in human hepatocellular carcinomaSurgery, 2004
- Expression of hepatoma‐derived growth factor in hepatocellular carcinomaCancer, 2003
- EBAG9/RCAS1 expression in hepatocellular carcinoma: correlation with tumour dedifferentiation and proliferationEuropean Journal of Cancer, 2003
- Hepatocyte growth factor, transforming growth factor α, and their receptors as combined markers of prognosis in hepatocellular carcinomaMolecular Carcinogenesis, 2003
- Prognostic factors of hepatic resection for hepatocellular carcinoma with cirrhosis: Univariate and multivariate analysisJournal of Surgical Oncology, 2002
- Downregulation of Proapoptotic Proteins Bax and Bcl-XS in p53 Overexpressing Hepatocellular CarcinomasBiochemical and Biophysical Research Communications, 2000
- Predictable factors for estimating prognosis of patients after resection of hepatocellular carcinomaCancer, 1993